DAA2241 |
toll-like receptor 5 increases with age |
Molecular |
frontal lobe |
Human |
TLR5 |
48.7% Increase Gene Expression Level |
|
DAA2228 |
toll-like receptor 5 increases with age |
Molecular |
parietal lobe |
Human |
TLR5 |
69.2% Increase Gene Expression Level |
|
DAA2213 |
toll-like receptor 7 increases with age |
Molecular |
hippocampus |
Human |
TLR7 |
94.7% Increase Gene Expression Level |
|
DAA2214 |
toll-like receptor 7 increases with age |
Molecular |
hippocampus |
Human |
TLR7 |
56.5% Increase Gene Expression Level |
|
DAA2229 |
toll-like receptor 7 increases with age |
Molecular |
parietal lobe |
Human |
TLR7 |
38.8% Increase Gene Expression Level |
|
DAA2215 |
Toll-like receptor 8 increases with age |
Molecular |
hippocampus |
Human |
TLR8 |
39.7% Increase Gene Expression Level |
|
DAA239 |
translocase of inner mitochondrial membrane 17 homolog A (yeast) |
Molecular |
brain |
Human |
TIMM17A |
13.0% Decrease Gene Expression Level |
|
DAA2030 |
Transmission of visible light through eye lenses decreases |
Physiological |
lens |
Human |
— |
— |
|
DAA1067 |
transporter activity decreases |
Molecular |
blood brain barrier |
Human |
— |
— |
|
DAA205 |
tripartite motif-containing 27 |
Molecular |
brain |
Human |
TRIM27 |
5.0% Decrease Gene Expression Level |
|
DAA242 |
trophoblast glycoprotein |
Molecular |
brain |
Human |
TPBG |
13.0% Decrease Gene Expression Level |
|
DAA244 |
TSPY-like 2 |
Molecular |
brain |
Human |
TSPYL2 |
14.0% Decrease Gene Expression Level |
|
DAA243 |
tubulin polymerization promoting protein |
Molecular |
brain |
Human |
TPPP |
21.0% Decrease Gene Expression Level |
|
DAA250 |
WD repeat and SOCS box-containing 2 |
Molecular |
brain |
Human |
WSB2 |
5.0% Decrease Gene Expression Level |
|
DAA241 |
tumor necrosis factor receptor superfamily, member 21 |
Molecular |
brain |
Human |
TNFRSF21 |
18.0% Decrease Gene Expression Level |
|
DAA252 |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
Molecular |
brain |
Human |
YWHAZ |
10.0% Decrease Gene Expression Level |
|
DAA1108 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
temporal lobe |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1106 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
frontal lobe |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1107 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
pons |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA1105 |
UDP-Gal:betaGal Beta 1,3-galactosyltransferase Polypeptide 6 |
Molecular |
cerebellum |
Human |
B3GALT6 |
Increase DNA Methylation |
|
DAA778 |
Variability of performance for multiple cognitive tasks increases |
Psychological |
brain |
Human |
— |
— |
|
DAA776 |
Verbal memory declines |
Psychological |
brain |
Human |
— |
— |
|
DAA50 |
versican |
Molecular |
brain |
Human |
VCAN |
20.0% Increase Gene Expression Level |
|
DAA245 |
vesicle-associated membrane protein 2 (synaptobrevin 2) |
Molecular |
brain |
Human |
VAMP2 |
4.0% Decrease Gene Expression Level |
|
DAA246 |
vesicle-associated membrane protein 3 (cellubrevin) |
Molecular |
brain |
Human |
VAMP3 |
7.0% Increase Gene Expression Level |
|